|
MechanismIL-1β inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
|
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismSYNGAP1 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Allinky Biopharma SL
0 Patents (Medical) associated with Allinky Biopharma SL
100 Deals associated with Allinky Biopharma SL
100 Translational Medicine associated with Allinky Biopharma SL